Standards & Testing
Quality is a measurement, not a claim.
≥99%
Minimum HPLC purity across the released catalogue
100%
Lots subjected to independent third-party analysis
<0.5 EU/mg
Endotoxin ceiling on released material
24 HRS
Standard dispatch window on in-stock compounds
Section 01 — Verification
The burden of proof sits with us.
Solid-Phase Synthesis
Every compound is produced via Fmoc solid-phase peptide synthesis in ISO-classified US facilities.
HPLC + MS Verification
Dual analysis on each lot: reverse-phase HPLC for purity, mass spectrometry for identity confirmation.
Lot-Matched COA
A Certificate of Analysis is attached to the exact lot number printed on your vial — never a generic sample.
Cold Chain Handling
Lyophilized under vacuum, stored at -20°C and dispatched with insulated packaging and ice packs.
Certificates of Analysis
Lot-matched proof, not a generic sample.
Every vial ships with a Certificate of Analysis tied to its exact lot — HPLC purity, mass-spec identity, and endotoxin results for that batch. Tap any lot below to view its original COA in full.
Semax 5mg
Bioviridian · Code COA2607
Lot
SK10-010226
Purity
99.8%
Content
4.98 mg
Dated
Sep 18, 2026
Selank 5mg
Analytical Formulations, Inc.
Lot
SK10-02232026
Purity
99.5%
Content
5.12 / 4.98 mg
Dated
Sep 18, 2026
Tesamorelin 10mg
Analytical Formulations, Inc.
Lot
TESA10-03112026
Purity
99.6%
Content
11.00 / 10.87 mg
Dated
Sep 18, 2026
Wolverine (TB-500 + BPC-157) 20mg
Analytical Formulations, Inc.
Lot
WLV10-02072026
Purity
—
Content
TB-500 20.60/20.33 · BPC-157 20.33/20.38 mg
Dated
Sep 18, 2026
Retatrutide 30mg
ACS Peptide Testing Labs · AAHT652
Lot
1977 · AAHT652
Purity
99.88%
Content
Retatrutide 99.88%
Dated
Aug 20, 2026
GLP-3 (Retatrutide) 10mg
ILS Laboratories · COA-2026-953677
Lot
PA1236
Purity
99.47%
Content
10.65 mg
Dated
Aug 28, 2026
NAD+ 500mg
Analytical Formulations, Inc.
Lot
N/A
Purity
99.9%
Content
558.9 / 548.6 mg
Dated
Aug 20, 2026
GHK-Cu 50mg
ILS Laboratories · COA-2026-953674
Lot
PA1175
Purity
99.71%
Content
53.27 mg
Dated
Jul 10, 2026
Bacteriostatic Water 3mL
Bioviridian · Code COA2609
Lot
BAC3-01242026
Purity
99.8%
Content
1.0538% BA
Dated
Jan 24, 2026
CJC-1295 (No DAC) + Ipamorelin 10mg
Analytical Formulations, Inc.
Lot
CP10-02122026
Purity
—
Content
CJC 10.12/10.20 · IPA 10.49/10.57 mg
Dated
Sep 18, 2026
MOTS-c 10mg
Analytical Formulations, Inc.
Lot
MC10-03102026
Purity
99.6%
Content
11.00 / 10.87 mg
Dated
Sep 18, 2026
Section 02 — Production
From resin to release.
Synthesis
Sequences are assembled residue by residue on resin, then cleaved and precipitated under controlled conditions.
Purification
Preparative reverse-phase HPLC isolates the target fraction; anything below 99.5% is rejected outright.
Lyophilization
The purified fraction is shell-frozen and freeze-dried into a stable, transport-ready cake.
Release
Independent laboratory testing confirms purity and mass before the lot is assigned a COA and released.